Saskatchewan Immunization Manual
... differentiate cell populations (e.g., CD4 cells = Th cells and CD8 cells = CTLs). Cell line ‐ Cells which can be cloned and propagated indefinitely in tissue culture. Cell‐mediated immune (CMI) response ‐ A term used to describe immune reactions that are mediated by cells (e.g. CTL cells) rather ...
... differentiate cell populations (e.g., CD4 cells = Th cells and CD8 cells = CTLs). Cell line ‐ Cells which can be cloned and propagated indefinitely in tissue culture. Cell‐mediated immune (CMI) response ‐ A term used to describe immune reactions that are mediated by cells (e.g. CTL cells) rather ...
Infectious Bronchitis in Parent Stock
... With all the different IBV strains that exist around the world, establishing the correct vaccination program is difficult, however antibodies produced to one variant often show (part) cross protection to other variants. Where prevalent strains in an area have been identified, designing a vaccine pro ...
... With all the different IBV strains that exist around the world, establishing the correct vaccination program is difficult, however antibodies produced to one variant often show (part) cross protection to other variants. Where prevalent strains in an area have been identified, designing a vaccine pro ...
PHS 398 (Rev. 9/04), Biographical Sketch Format Page
... the immune response in this subset of patients differs from the majority of HIV infected people is crucial for HIV vaccine development and therapy. The major goals of this project are to determine whether development of broadly neutralizing antibodies is correlated with less disrupted B lymphocyte c ...
... the immune response in this subset of patients differs from the majority of HIV infected people is crucial for HIV vaccine development and therapy. The major goals of this project are to determine whether development of broadly neutralizing antibodies is correlated with less disrupted B lymphocyte c ...
Meeting a Grand Challenge in Global Health Safer, Needle-Free, Unit-
... can be used to manufacture stable and potent dry powders of attenuated live measles vaccine with the necessary aerodynamic properties suitable for inhalation. • Two low cost Dry Powder Inhalers, PuffHaler and Solovent, along with packaging configurations for dry powders, were ...
... can be used to manufacture stable and potent dry powders of attenuated live measles vaccine with the necessary aerodynamic properties suitable for inhalation. • Two low cost Dry Powder Inhalers, PuffHaler and Solovent, along with packaging configurations for dry powders, were ...
Haemophilus influenzae type b (Hib) disease
... of the vaccine or any component of the vaccine should not • Avoid sharing food, drinks and eating utensils. receive the vaccine. Immunisation should be postponed in • Limit close physical contact when coughing and sneezing. subjects suffering from an acute illness or high fever. However, • Rememb ...
... of the vaccine or any component of the vaccine should not • Avoid sharing food, drinks and eating utensils. receive the vaccine. Immunisation should be postponed in • Limit close physical contact when coughing and sneezing. subjects suffering from an acute illness or high fever. However, • Rememb ...
Haemophilus influenzae type b (Hib) disease
... of the vaccine or any component of the vaccine should not • Avoid sharing food, drinks and eating utensils. receive the vaccine. Immunisation should be postponed in • Limit close physical contact when coughing and sneezing. subjects suffering from an acute illness or high fever. However, • Rememb ...
... of the vaccine or any component of the vaccine should not • Avoid sharing food, drinks and eating utensils. receive the vaccine. Immunisation should be postponed in • Limit close physical contact when coughing and sneezing. subjects suffering from an acute illness or high fever. However, • Rememb ...
Hepatitis B is a viral infection that attacks the liver and can cause
... There is no specific treatment for acute hepatitis B. Care is aimed at maintaining comfort and adequate nutritional balance, including replacement of fluids that are lost from vomiting and diarrhoea. Chronic hepatitis B can be treated with drugs, including interferon and anti-viral agents, which can ...
... There is no specific treatment for acute hepatitis B. Care is aimed at maintaining comfort and adequate nutritional balance, including replacement of fluids that are lost from vomiting and diarrhoea. Chronic hepatitis B can be treated with drugs, including interferon and anti-viral agents, which can ...
Attachment B - George Mason University
... Employee has been informed of results of the evaluation. Employee has been informed about any medical conditions resulting from exposure to blood or other potentially infectious materials which require further evaluation or treatment. Hepatitis vaccine is indicated for this employee. Employee has re ...
... Employee has been informed of results of the evaluation. Employee has been informed about any medical conditions resulting from exposure to blood or other potentially infectious materials which require further evaluation or treatment. Hepatitis vaccine is indicated for this employee. Employee has re ...
Fine-Scale Modeling of Global Plate Tectonics
... activity can be explained as a part of mantle convection. Relatively rigid lithospheric plates form the top, cold boundary layer of the convecting mantle, and the potential energy released during the cooling of the planet is balanced by viscous dissipation during deformation of mantle rocks (1, 2). ...
... activity can be explained as a part of mantle convection. Relatively rigid lithospheric plates form the top, cold boundary layer of the convecting mantle, and the potential energy released during the cooling of the planet is balanced by viscous dissipation during deformation of mantle rocks (1, 2). ...
Myths and concerns about vaccination
... same time as vaccination. This is particularly the case in the first year of a child’s life, when vaccines are given regularly. Events that occur in the child’s first year of life may therefore coincide with the time that a vaccine has been received. A good example of this is a sixmonth-old infant h ...
... same time as vaccination. This is particularly the case in the first year of a child’s life, when vaccines are given regularly. Events that occur in the child’s first year of life may therefore coincide with the time that a vaccine has been received. A good example of this is a sixmonth-old infant h ...
Document
... First lung cancer patient who received conventional therapy* followed by immunization with ICT’s DNA-based vaccine has ...
... First lung cancer patient who received conventional therapy* followed by immunization with ICT’s DNA-based vaccine has ...
International Hepatitis B Cure Workshop 2016 Therapeutic Vaccines
... • Poor recall response Adapted from Wherry et al, PNAS 2004 & JEM 2007, Cell 2015 ...
... • Poor recall response Adapted from Wherry et al, PNAS 2004 & JEM 2007, Cell 2015 ...
Immunology: Introduction and Overview
... invasive or pathogenic effects of foreign microorganisms or to the toxic effect of ...
... invasive or pathogenic effects of foreign microorganisms or to the toxic effect of ...
Haemophilus influenzae type b (Hib) disease
... to 6 years of age. Children under 2 years of age have a better immune response to Hib immunisation than to actual Hib disease. However, there are cases of immunised children getting Hib disease because immunisation is not 100% effective in every person who receives it. The booster dose in the second ...
... to 6 years of age. Children under 2 years of age have a better immune response to Hib immunisation than to actual Hib disease. However, there are cases of immunised children getting Hib disease because immunisation is not 100% effective in every person who receives it. The booster dose in the second ...
feline_panleukopenia
... • Most cases are sudden (acute), lasting only 5–7 days • If death does not occur during the sudden (acute) disease, recovery is usually rapid and uncomplicated; it may take several weeks for the pet to regain weight and body condition • Prognosis is guarded during the sudden (acute) disease, especia ...
... • Most cases are sudden (acute), lasting only 5–7 days • If death does not occur during the sudden (acute) disease, recovery is usually rapid and uncomplicated; it may take several weeks for the pet to regain weight and body condition • Prognosis is guarded during the sudden (acute) disease, especia ...
Feline Panleukopenia
... • Most cases are sudden (acute), lasting only 5–7 days • If death does not occur during the sudden (acute) disease, recovery is usually rapid and uncomplicated; it may take several weeks for the pet to regain weight and body condition • Prognosis is guarded during the sudden (acute) disease, especia ...
... • Most cases are sudden (acute), lasting only 5–7 days • If death does not occur during the sudden (acute) disease, recovery is usually rapid and uncomplicated; it may take several weeks for the pet to regain weight and body condition • Prognosis is guarded during the sudden (acute) disease, especia ...
IBR/Pii The humoral immune response in cattle after Pasteurella haemolytica
... A multivalent vaccine consisting of inactivated bovine herpes virus-1 (BHV-1), also known as infectious bovine rhinotracheitis virus (IBR) , para-influenza type-3 virus (PI 3 ) and the leukotoxin of Pasteurella haemolytica A 1, were combined with the addition of aluminium hydroxide as adjuvant, and ...
... A multivalent vaccine consisting of inactivated bovine herpes virus-1 (BHV-1), also known as infectious bovine rhinotracheitis virus (IBR) , para-influenza type-3 virus (PI 3 ) and the leukotoxin of Pasteurella haemolytica A 1, were combined with the addition of aluminium hydroxide as adjuvant, and ...
Adenovirus vectors
... pathogens. A recombinant adenohepatitis vaccine Wy-Ad7HZ6-I, which expressed hepatitis B surface antigen and contained a large deletion in early region 3 (E3), was constructed and studied in humans. Volunteers received Wy-Ad7HZ6-I (n = 3), adenovirus type 7 vaccine (n = 3) or placebo (n = 3). Recipi ...
... pathogens. A recombinant adenohepatitis vaccine Wy-Ad7HZ6-I, which expressed hepatitis B surface antigen and contained a large deletion in early region 3 (E3), was constructed and studied in humans. Volunteers received Wy-Ad7HZ6-I (n = 3), adenovirus type 7 vaccine (n = 3) or placebo (n = 3). Recipi ...
Adenovirus vectors - Baylor College of Medicine
... pathogens. A recombinant adenohepatitis vaccine Wy-Ad7HZ6-I, which expressed hepatitis B surface antigen and contained a large deletion in early region 3 (E3), was constructed and studied in humans. Volunteers received Wy-Ad7HZ6-I (n = 3), adenovirus type 7 vaccine (n = 3) or placebo (n = 3). Recipi ...
... pathogens. A recombinant adenohepatitis vaccine Wy-Ad7HZ6-I, which expressed hepatitis B surface antigen and contained a large deletion in early region 3 (E3), was constructed and studied in humans. Volunteers received Wy-Ad7HZ6-I (n = 3), adenovirus type 7 vaccine (n = 3) or placebo (n = 3). Recipi ...
Article 1: Mucosal Immunity and Vaccines
... block disease development once the pathogen has crossed the mucosal barrier into the normally sterile systemic environment [13]. Mucosal vaccines have several advantages over traditional systemic vaccines. They can be administered orally or nasally rather than via injection. This is more widely acce ...
... block disease development once the pathogen has crossed the mucosal barrier into the normally sterile systemic environment [13]. Mucosal vaccines have several advantages over traditional systemic vaccines. They can be administered orally or nasally rather than via injection. This is more widely acce ...
Meningococcal Disease
... first place. Two types of effective vaccines have been developed against the specific types of Neisseria meningitidis that cause most cases of meningococcal disease. Meningococcal vaccines are among those that are routinely given to children. The vaccination is recommended for children between the a ...
... first place. Two types of effective vaccines have been developed against the specific types of Neisseria meningitidis that cause most cases of meningococcal disease. Meningococcal vaccines are among those that are routinely given to children. The vaccination is recommended for children between the a ...
What parents should know about vaccination and diseases targeted
... • People most at risk: Polioviruses mainly affect children under five years of age but might occur at any age. Risk of paralysis following infection is increased in some cases such as immune compromised, pregnant, and others. ...
... • People most at risk: Polioviruses mainly affect children under five years of age but might occur at any age. Risk of paralysis following infection is increased in some cases such as immune compromised, pregnant, and others. ...
Vaccine
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing micro-organism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and keep a record of it, so that the immune system can more easily recognize and destroy any of these micro-organisms that it later encounters.The administration of vaccines is called vaccination. The effectiveness of vaccination has been widely studied and verified; for example, the influenza vaccine, the HPV vaccine, and the chicken pox vaccine. Vaccination is the most effective method of preventing infectious diseases; widespread immunity due to vaccination is largely responsible for the worldwide eradication of smallpox and the restriction of diseases such as polio, measles, and tetanus from much of the world. The World Health Organization (WHO) reports that licensed vaccines are currently available to prevent or contribute to the prevention and control of twenty-five infections.Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or ""wild"" pathogen), or therapeutic (e.g., vaccines against cancer are also being investigated; see cancer vaccine).The terms vaccine and vaccination are derived from Variolae vaccinae (smallpox of the cow), the term devised by Edward Jenner to denote cowpox. He used it in 1798 in the long title of his Inquiry into the...Variolae vaccinae...known...[as]...the Cow Pox, in which he described the protective effect of cowpox against smallpox. In 1881, to honour Jenner, Louis Pasteur proposed that the terms should be extended to cover the new protective inoculations then being developed.